Type I Interferon as a Target of Treatment in SLE

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 323-330

Bentham Science Publishers

Access to resources Recommend Favorite

Primary Sjogren's Syndrome and the Type I Interferon System

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 2054-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma

By Smit J.J.   Van Loveren H.   Hoekstra M.O.   Van der Kant P.A.A.   Folkerts G.   Nijkamp F.P.  

European Journal of Pharmacology, Vol. 470, Iss. 3, 2003-06 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Myobacterium tuberculosis

By Seed M. P.  

Inflammopharmacology, Vol. 12, Iss. 5-6, 2004-12 ,pp. : 551-567

VSP

Access to resources Recommend Favorite

Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli

By Cortes-Perez Naima G.   Azevedo Vasco   Alcocer-González Juan M.   Rodriguez-Padilla Cristina   Tamez-Guerra Reyes S.   Corthier Gérard   Gruss Alexandra   Langella Philippe   Bermúdez-Humarán Luis G.  

Journal of Drug Targeting, Vol. 13, Iss. 2, 2005-02 ,pp. : 89-98

Informa Healthcare

Access to resources Recommend Favorite